BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, April 27, 2026
Home » Authors » Lynn Yoffee

Articles by Lynn Yoffee

FDA clears biospace med's 3-D/standing X-ray system

Oct. 10, 2008
By Lynn Yoffee
Surgeons now have a much more realistic image to use when planning spine and knee procedures with the FDA's 510(k) clearance this week of biospace med's (Paris/Marietta, Georgia) X-ray imaging system, the first that allows patients to stand up during the process and produces 3-D images. (Medical Device Daily)
Read More

DiagNano's quantum dots offer more accurate disease detection

Oct. 9, 2008
By Lynn Yoffee
ATLANTA — While Georgia Institute of Technology (Georgia Tech; Atlanta) student Brad Kairdolf was studying biomedical engineering, his wife Alyssa was diagnosed with thyroid cancer. Because the first pathology report was negative, she ended up having to go back into surgery a week after the initial biopsy when further analysis of the tissue sample confirmed cancer. (Diagnostics & Imaging Week)
Read More

DiagNano's quantum dots offer more accurate disease detection

Oct. 3, 2008
By Lynn Yoffee

Cepheid's GeneXpert rapid MRSA test wins FDA approval

Oct. 2, 2008
By Lynn Yoffee
There is light at the end of the infection control tunnel – particularly when it comes to the growing incidences of methicillin-resistant Staphylococcus aureus (MRSA) infections – with the FDA's clearance this week of Cepheid's (Sunnyvale, California) GeneXpert MRSA/SA Skin and Soft Tissue Infection (SSTI) test, which can provide clinicians with results in less than a hour, compared to traditional cultured tests which can take days. (Diagnostics & Imaging Week)
Read More

SwiftMD starts as first 24/7 emergency physician access

Oct. 2, 2008
By Lynn Yoffee

CartiMesh may be next best knee repair on the horizon

Oct. 2, 2008
By Lynn Yoffee

Cepheid's GeneXpert rapid MRSA test wins FDA approval

Oct. 1, 2008
By Lynn Yoffee
There is light at the end of the infection control tunnel – particularly when it comes to the growing incidences of methicillin-resistant Staphylococcus aureus (MRSA) infections – with the FDA's clearance this week of Cepheid's (Sunnyvale, California) GeneXpert MRSA/SA Skin and Soft Tissue Infection (SSTI) test, which can provide clinicians with results in less than a hour, compared to traditional cultured tests which can take days. (Medical Device Daily)
Read More

SwiftMD starts as first 24/7 emergency physician access

Sep. 29, 2008
By Lynn Yoffee

Steady growth of med tech in Georgia's 'Innovation Crescent'

Sep. 26, 2008
By Lynn Yoffee
ATLANTA – Georgia may not be an official biotech or med-tech hotbed, but it's moving in that direction as demonstrated by the breadth of companies and researchers featured during this week's Georgia Life Sciences Summit 2008. And, despite venture capital funding difficulties in recent times, the state has seen steady growth with 300 life sciences companies calling the southern state home that now boasts nearly $8 billion in annual sales of 400 life science products. (Medical Device Daily)
Read More

Prosthetic vein valve developed at Ga Tech may offer solution for CVI

Sep. 23, 2008
By Lynn Yoffee
Previous 1 2 … 28 29 30 31 32 33 34 35 36 … 50 51 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 27, 2026.
  • Illustration of a tumor

    Detecting the invisible: minimal residual disease at AACR 2026

    BioWorld Science
    Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
  • Boy cupping ear with soundwave graphic

    A free gene therapy? Regeneron’s Otarmeni approved for hearing loss

    BioWorld
    Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
  • Illustration of human face that looks abstract and digital

    AACR 2026: The age of agentic AI in oncology

    BioWorld Science
    New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
  • Chengdu Mfs Pharma synthesizes new compounds for pain

    BioWorld Science
    Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing